Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/26 12:14:40 pm
296.285 USD   +0.46%
12:05pEuropean ADRs Move Higher in Tuesday Trading
MT
10:48aPfizer, BioNTech Edge Closer to US FDA's OK for Kid-Size Doses of COVID-19 Vaccine
MT
10:37aBioNTech to work with Senegal, Rwanda to make mRNA vaccines
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BioNTech : Canaccord Genuity Adjusts BioNTech's Price Target to $450 From $240, Keeps Buy Rating

08/20/2021 | 09:32am EDT


© MT Newswires 2021
All news about BIONTECH SE
12:05pEuropean ADRs Move Higher in Tuesday Trading
MT
10:48aPfizer, BioNTech Edge Closer to US FDA's OK for Kid-Size Doses of COVID-19 Vaccine
MT
10:37aBioNTech to work with Senegal, Rwanda to make mRNA vaccines
AQ
09:59aBioNTech Plans to Start the Construction of an mRNA Vaccine Manufacturing Facility in A..
MT
08:46aBioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility i..
PU
08:41aBioNTech To Build mRNA COVID-19 Vaccine Facilities In Africa
MT
08:16aBioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility i..
PU
08:01aBioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility ..
GL
08:00aPRESS RELEASE : BioNTech Plans to Initiate the -2-
DJ
08:00aPRESS RELEASE : BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturi..
DJ
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 16 703 M 19 352 M 19 352 M
Net income 2021 8 797 M 10 192 M 10 192 M
Net cash 2021 8 661 M 10 035 M 10 035 M
P/E ratio 2021 7,23x
Yield 2021 -
Capitalization 61 368 M 71 229 M 71 101 M
EV / Sales 2021 3,16x
EV / Sales 2022 2,54x
Nbr of Employees 2 500
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 254,09 €
Average target price 254,59 €
Spread / Average Target 0,20%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE261.78%71 229
GILEAD SCIENCES, INC.16.15%84 845
WUXI APPTEC CO., LTD.24.08%64 399
REGENERON PHARMACEUTICALS19.27%59 906
VERTEX PHARMACEUTICALS-21.73%47 992
BEIGENE, LTD.49.95%36 160